AbbVie Inc.
ABBV 271.36 (2.20%) 5.97
EV: $570.14(B)
Total Equity: $-5.89(B)
Debt/Equity: 48
Dividend/share: $6.8
Div. yield: 2.52%
P/E: 76.66
Forward P/E: 19.37
P/FCF: 26.32
P/S: 7.46
P/B: N/A
EPS: $3.5
EPS (fwd): $14.0
FCF/share: $10.3
Revenue/share: $36.4
Book value/share: $-3.4
ROIC: 3.3%
ROA: 1.7%
ROE: 140.9%
Margins: Gross | Op. | Net
72.8% | 24.1% | 9.8%
0.0%of Portfolio
My holdings
Day change
Total change
Est. EPS Growth > 5%
5Y Shares Out Change < 0% ROIC > 10% Debt/Equity < 1 Current Ratio > 1 Quick Ratio > 1 Net Margin > 10% Past Net Income CAGR > 0%
TTM Financials
Income (TTM)
Revenue$64.39(B)
Gross profit$46.87(B)
EBITDA$30.76(B)
Net income$6.31(B)
Gross margin72.8%
Operating margin24.1%
Net margin9.8%
Shares outstanding1.77(B)
Balance sheet
Total assets$135.12(B)
Current assets$33.67(B)
Total liabilities$141.00(B)
Current liabilities$41.64(B)
Cash & Short-term inv.$6.57(B)
Long-term debt$62.53(B)
Total intangibles$84.66(B)
PP&E$5.80(B)
Cash flow (TTM)
FCF$18.21(B)
CapEx$-1.30(B)
Dividends paid$-11.98(B)
Stock issued$172.00(M)
Stock repurchased$-1.50(B)
Stock-based comp.$1.07(B)
Debt issued$7.73(B)
Debt repaid$-7.31(B)